Recurrence of condylomata acuminata of the urethra after conventional and fluorescence-controlled Nd:YAG laser treatment

Urology

Volumn 61, Issue 5, 2003, Pages 1011-1015

  Zaak, D ^a   Hofstetter, A ^a   Frimberger, D ^a   Schneede, Peter ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC SURGERY; FLUORESCENCE; HUMAN; INSTRUMENTATION; INTERMETHOD COMPARISON; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; URETHRA; URETHRA STRICTURE; VIRAL CONTAMINATION; VIRUS INFECTION; WART VIRUS; WHITE LIGHT;

EID: 0037963936     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02527-X     Document Type: Article

References (15)

1. Oriel J.D. Natural history of genital warts. Br J Venereal Dis. 47:1970;1-13.
2. McKenna J.G., McMillan A. Management of intrameatal warts in men. Int J STD AIDS. 1:1990;259-263.
3. Hofstetter A.G. Lasers in Urological Surgery. 1997;47-56 Springer, Berlin.
4. Schneede P., Leunig A., Hillemanns P., et al. Photodynamic investigation of mucosa-associated human papillomavirus (HPV) efflorescences. BJU Int. 88:2001;117-119.
5. Schneede P., Münch P., Wagner S., et al. Fluorescence urethroscopy following instillation of 5-aminolevulinic acid a new procedure for detecting clinical and subclinical HPV lesions of the urethra . J Eur Acad Dermatol Venereol. 15:2001;121-125.
6. National guidelines for the management of anogenital warts. Sex Transm Inf. 75:1999;S71-S75.
7. Ferenczy A., Bergeron C.H., Richart R.M. Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections. Obstet Gynecol. 74:1989;950-954.
8. Ferenczy A., Mitao M., Nagai N., et al. Latent papillomavirus and recurring genital warts. N Engl J Med. 313:1985;784-788.
9. Lazcano-Ponce E., Herrero R., Munoz N., et al. High prevalence of human papillomavirus infection in Mexican males comparative study of penile-urethral swabs and urine samples . Sex Transm Dis. 28:2001;277-280.
10. Von Krogh G., Lacey C.J.N., Gross G., et al. European course on HPV associated pathology guidelines for primary care physicians for the diagnosis and management of anogenital warts . Sex Transm Inf. 76:2000;162-168.
11. Maw R.D., Reitano M., Roy M. An international survey of patients with genital warts perceptions regarding treatment and impact on lifestyle . Int J STD AIDS. 9:1998;571-578.
12. Beutner K.R., Ferenczy A. Therapeutic approaches to genital warts. Am J Med. 102:1997;28-37.
13. Lacey C.J.N., Fairley I. Medical therapy of genital human papilloma virus-related disease. Int J STD AIDS. 6:1995;399-407.
14. Böhle A., Doehn C., Kausch I., et al. Treatment of recurrent penile condylomata acuminata with external application and intraurethral instillation of bacillus Calmette-Guérin. J Urol. 160:1998;394-396.
15. Levine L.A., Elterman L., Rukstalis D.B. Treatment of subclinical intraurethral human papilloma virus infection with interferon alfa-2B. Urology. 47:1996;553-557.